Published in Clin Exp Immunol on August 01, 1979
Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A (2009) 2.29
Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol (2011) 2.15
Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol (2003) 1.55
Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun (1986) 1.48
Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol (1999) 1.33
Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology (1988) 1.15
Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clin Diagn Lab Immunol (1999) 0.98
Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages. Infect Immun (1984) 0.88
Lipopolysaccharide-Induced Profiles of Cytokine, Chemokine, and Growth Factors Produced by Human Decidual Cells Are Altered by Lactobacillus rhamnosus GR-1 Supernatant. Reprod Sci (2014) 0.77
Immunogenic properties of Lactobacillus plantarum producing surface-displayed Mycobacterium tuberculosis antigens. Appl Environ Microbiol (2016) 0.75
Granulomatous inflammations. Prog Allergy (1978) 2.31
Phagocyte lysosomes: interactions with infectious agents, phagosomes, and experimental perturbations in function. Annu Rev Microbiol (1977) 2.19
The primary immune response in mice. I. The enhancement and suppression of hemolysin production by a bacterial endotoxin. J Exp Med (1968) 2.12
Stimulation of humoral antibody formation by polyanions. I. The effect of polyacrylic acid on the primary immune response in mice immunized with sheep red blood cells. Eur J Immunol (1971) 1.61
Stimulation of humoral antibody formation by polyanions. II. The influence of sulfate esters of polymers on the immune response in mice. Eur J Immunol (1971) 1.52
Preparation of arthritogenic hydrosoluble peptidoglycans from both arthritogenic and non-arthritogenic bacterial cell walls. Infect Immun (1977) 1.38
Killed Listeria monocytogenes vaccine becomes protective on addition of polyanions. Nature (1977) 1.34
Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology (1977) 1.33
Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31
Influence of cyclophosphamide on the delayed hypersensitivity in the mouse after intraperitoneal immunization. Ann Immunol (Paris) (1974) 1.23
Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen. Infect Immun (1977) 1.11
Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes: enhancement of antibody formation by using subcutaneous administration of adjuvant and antigen. Infect Immun (1975) 1.02
Use of carrageenan as an adjuvant of delayed hypersensitivity. Int Arch Allergy Appl Immunol (1974) 0.92
Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours. Int J Cancer (1976) 0.92
Differential effects of concanavalin A and phytohemagglutinin on murine immunity. Suppression and enhancement of humoral immunity. Cell Immunol (1977) 0.91
Antigen-sensitive spleen cells and the adjuvant activity of Bordetella pertussis. Can J Microbiol (1970) 0.87
The adjuvant active fraction of delipidated mycobacteria. Nature (1977) 0.87
Influence of cyclophosphamide on the delayed hypersensitivity of the mouse. Ann Immunol (Paris) (1974) 2.38
Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrol Dial Transplant (2011) 2.04
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun (1999) 1.87
Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6. FEMS Immunol Med Microbiol (1993) 1.84
Anti-inflammatory activity of gallic acid. Planta Med (1992) 1.69
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
Selection at the alcoholdehydrogenase locus in Drosophila melanogaster. Experientia (1975) 1.66
Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int (2007) 1.63
Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia (2010) 1.60
Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am J Transplant (2009) 1.53
Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J Immunol Methods (1983) 1.53
GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy. Kidney Int (2008) 1.52
Influence of cyclophosphamide on delayed hypersensitivity and acquired cellular resistance to Listeria monocytogenes in the mouse. Immunology (1977) 1.52
Dimethyl diotadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice. Immunology (1977) 1.51
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen. Immunology (1979) 1.47
Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol (1996) 1.46
Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther (1997) 1.37
Killed Listeria monocytogenes vaccine becomes protective on addition of polyanions. Nature (1977) 1.34
Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis. Antimicrob Agents Chemother (1996) 1.23
Transformation of type polysaccharide antigen synthesis and hemolysin synthesis in streptococci. J Bacteriol (1968) 1.22
Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3. Infect Immun (1983) 1.21
Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet (2000) 1.20
Cellular localization and tissue distribution of polycystin-1. J Pathol (1999) 1.18
Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis. FEMS Immunol Med Microbiol (1995) 1.18
The influence of cyclophosphamide on antibody formation in the mouse. Ann Immunol (Paris) (1975) 1.18
Loss of type antigen in a type 3 streptococcus and identification of the determinant disaccharide of the remaining antigen. J Gen Microbiol (1967) 1.14
Estimation of classical pathway of mouse complement activity by use of sensitized rabbit erythrocytes. J Immunol Methods (1980) 1.12
Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. J Infect Dis (1994) 1.11
Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect Immun (1994) 1.10
Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. Eur J Cell Biol (1995) 1.10
Possible involvement of terminal complement complex in active Heymann nephritis. Kidney Int (1985) 1.09
Opsonic defense to Staphylococcus epidermidis in the premature neonate. J Infect Dis (1985) 1.07
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin? J Bacteriol (1999) 1.06
Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer. Mol Microbiol (2000) 1.06
Cells involved in the graft-versus-host reaction in vitro. Immunology (1973) 1.06
Complement resistance in Branhamella (Moraxella) catarrhalis. Lancet (1993) 1.06
Distinctive roles of neutrophils and monocytes in anti-thy-1 nephritis. Am J Pathol (2000) 1.05
Adjuvant effect of nonionic block polymer surfactants in humoral and cellular immunity. Int Arch Allergy Appl Immunol (1981) 1.02
Immunochemistry of the carbohydrate antigens of some Streptococcus salivarius strains. J Gen Microbiol (1971) 1.02
The role of Peyer's patch cells in antibody formation. Immunology (1973) 1.01
Complement-resistant Moraxella catarrhalis forms a genetically distinct lineage within the species. FEMS Microbiol Lett (2000) 1.01
The popliteal lymph node assay in mice to screen for the immune disregulating potential of chemicals--a preliminary study. Int J Immunopharmacol (1989) 1.01
Optimal method for RNA extraction from mouse glomeruli. Nephrol Dial Transplant (1994) 1.01
Apocynin, a plant-derived, cartilage-saving drug, might be useful in the treatment of rheumatoid arthritis. Rheumatology (Oxford) (1999) 1.01
Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3. Infect Immun (1983) 1.01
Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol (2001) 1.00
Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis (2000) 0.99
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. II. Induction of delayed-type hypersensitivity. Immunology (1981) 0.99
Determination of alternative pathway of complement activity in mouse serum using rabbit erythrocytes. J Immunol Methods (1980) 0.99
Lymph node cells from rats with Heymann's nephritis produce in vitro autoantibodies directed against purified renal tubular antigen. Immunology (1984) 0.99
Inhibition of human complement by beta-glycyrrhetinic acid. Immunology (1997) 0.98
Immunomodulatory and anti-inflammatory activity of Picrorhiza scrophulariiflora. J Ethnopharmacol (2000) 0.98
Association of familial deficiency of mannose-binding lectin and meningococcal disease. Lancet (1999) 0.97
New, simple medium for selective recovery of Klebsiella pneumoniae and Klebsiella oxytoca from human feces. J Clin Microbiol (1984) 0.96
Interactions of killed Listeria monocytogenes with the mouse complement system. Infect Immun (1981) 0.96
Glomeruli synthesize nitrite in active Heymann nephritis; the source is infiltrating macrophages. Kidney Int (1991) 0.96
Delayed-type hypersensitivity and acquired cellular resistance in mice immunized with killed Listeria monocytogenes and adjuvants. Immunology (1979) 0.95
Adult, fetal, and polycystic kidney expression of polycystin, the polycystic kidney disease-1 gene product. Lab Invest (1996) 0.95
Distribution of fibronectin isoforms in human renal disease. J Pathol (2001) 0.94
Distribution of different cell types in the lymphoid organs of the mouse, as determined with sera against thymus and Peyer's patches. Immunology (1974) 0.94
Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice. Cancer Immunol Immunother (1987) 0.94
Histamine 2 receptor-mediated immunomodulation in the mouse. I. Immunomodulation by the H2 agonist tolazoline. Clin Exp Immunol (1979) 0.94
Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology. J Lab Clin Med (1994) 0.94
Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide. Infect Immun (1985) 0.93
ECM homeostasis in renal diseases: a genomic approach. J Pathol (2003) 0.93
Effects of variation in time and dose of cyclophosphamide injection on delayed hypersensitivity and antibody formation. Cell Immunol (1977) 0.93
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity. Immunology (1981) 0.93
Killed Listeria monocytogenes vaccine is protective in C3H/HeJ mice without addition of adjuvants. Nature (1980) 0.92
Cellular and humoral adjuvant activity of mistletoe extract. Immunobiology (1979) 0.92
Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1995) 0.92
Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein. Infect Immun (1998) 0.92
Two functionally and chemically distinct immunomodulatory compounds in the gel of Aloe vera. J Ethnopharmacol (1988) 0.91
Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese. Diabetes Res Clin Pract (2009) 0.91
Immunomodulating properties of two synthetic adjuvants: dependence upon type of antigen, dose, and time of administration. Cell Immunol (1984) 0.91
The autoimmune response in active Heymann's nephritis in Lewis rats is regulated by T-lymphocyte subsets. Cell Immunol (1985) 0.91
Regulatory T-lymphocytes in asthma. Eur Respir J (2005) 0.90
Murine systemic autoimmune disease induced by mercuric chloride: T helper cells reacting to self proteins. Int Arch Allergy Immunol (1996) 0.90
Antigenic specificities of glomerular-bound autoantibodies in membranous glomerulopathy induced by mercuric chloride. Clin Immunol Immunopathol (1992) 0.89
Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicity. Toxicol Appl Pharmacol (2001) 0.88
Effects of lactobacilli on parameters of non-specific resistance of mice. Med Microbiol Immunol (1981) 0.88
Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response. J Immunol (1987) 0.88
Differential expression of collagen IV isoforms in experimental glomerulosclerosis. J Pathol (1998) 0.88
Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients. Am J Transplant (2010) 0.87
The environmental pollutant hexachlorobenzene causes eosinophilic and granulomatous inflammation and in vitro airways hyperreactivity in the Brown Norway rat. Arch Toxicol (2002) 0.87
Synergic action between tumor necrosis factor and endotoxins or poly(A.U) on cultured bovine endothelial cells. Cancer Immunol Immunother (1989) 0.87
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VI. Response in B-cell-defective CBA/N mice. Immunology (1982) 0.87
A one-step isolation procedure for phospholipase A2-free cobra venom factor by fast protein liquid chromatography. J Immunol Methods (1987) 0.86
Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniques. J Immunol Methods (1988) 0.86
Modulation of airway hyperresponsiveness by thiols in a murine in vivo model of allergic asthma. Inflamm Res (2003) 0.86
Pancreatic ribonuclease distribution and comparisons in mammals. Nat New Biol (1973) 0.86
Complement split product C5a mediates the lipopolysaccharide-induced mobilization of CFU-s and haemopoietic progenitor cells, but not the mobilization induced by proteolytic enzymes. Cell Tissue Kinet (1986) 0.86
Collagen types VIII and X, two non-fibrillar, short-chain collagens. Structure homologies, functions and involvement in pathology. Histol Histopathol (1997) 0.86
Effects of immunosuppressive treatment on the in vitro activity of mouse lymphoid cells after stimulation by PHA and allogeneic cells. Int Arch Allergy Appl Immunol (1973) 0.86
Anti-C1q autoantibodies in murine lupus nephritis. Clin Exp Immunol (2004) 0.86
Autoimmune effects of hexachlorobenzene in the rat. Toxicol Appl Pharmacol (1993) 0.85